Addiction Research

According to the World Health Organization (WHO), addiction is 'a chronic disease of the central nervous system that is characterized by a loss of control over impulsive behavior that leads to compulsive drug seeking and taking, and to relapses even after months of abstinence'. Addiction is a complex neuroadaptive process, where drugs of abuse alter cellular and molecular aspects of neural function. The brain circuits mediating the various behavioral effects of these drugs are rendered more, or less, responsive to those effects.

Addiction Research Products Targets

Products for Addiction Research - Page 39

Cat.No. Product Name Information/Activity
BCC6551 DL-AP7 78966-69-5
BCC6631 Arcaine sulfate 14923-17-2
BCC6602 (R)-4-Carboxyphenylglycine 134052-68-9
BCC7078 CGP 37849 CGP 37849 is a potent, competitive and orally active N-methyl-D-aspartate (NMDA) receptor antagonist. CGP 37849 is an anticonvulsant in rodents and has antidepressant and anxiolytic-like effects.
BCC7053 CGP 39551 127910-32-1
BCC7087 CGP 78608 hydrochloride CGP 78608 hydrochloride is a highly potent and selective antagonist at the glycine-binding site of the NMDA receptor, with an IC50 of 6 nM. CGP 78608 acts as a potentiator of GluN1/GluN3A-mediated glycine currents, with an estimated EC50 in the low nM range (26.3 nM). Anticonvulsant activity.
BCC6986 CGS 19755 110347-85-8
BCC6805 (2R,3S)-Chlorpheg 140924-23-8
BCC7369 Co 101244 hydrochloride 193356-17-1
BCC6120 Conantokin G 93438-65-4